N4-Cyclopropyl-6-(2,3-dichlorophenyl)pyrimidine-2,4-diamine hydrochloride

Catalog No. :
ACKPCA216
CAS No. :
1640282-30-9
Molecular Formula :
C13H13Cl3N4
Molecular Weight :
331.63

IUPAC Name:N4-cyclopropyl-6-(2,3-dichlorophenyl)pyrimidine-2,4-diamine hydrochloride

N4-Cyclopropyl-6-(2,3-dichlorophenyl)pyrimidine-2,4-diamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$367.00Login to see priceInquiryInquiry
25mg98%$764.00Login to see priceInquiryInquiry
50mg98%$1065.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN4-Cyclopropyl-6-(2,3-dichlorophenyl)pyrimidine-2,4-diamine hydrochloride
IUPAC NameN4-cyclopropyl-6-(2,3-dichlorophenyl)pyrimidine-2,4-diamine hydrochloride
Molecular FormulaC13H13Cl3N4
Molecular Weight331.63
SMILESNC1=NC(C2=CC=CC(Cl)=C2Cl)=CC(NC3CC3)=N1.[H]Cl
InChI KeyFBHMEHNWFXCSKE-UHFFFAOYSA-N
SynonymTH588 (hydrochloride);TH588 HCl;6-(2,3-dichlorophenyl)-N4-cyclopropylpyrimidine-2,4-diamine hydrochloride;4-N-cyclopropyl-6-(2,3-dichlorophenyl)pyrimidine-2,4-diamine;TH-588 hydrochloride (TH588 hydrochloride);n4-cyclopropyl-6-(2,3-dichlorophenyl)pyrimidine-2,4-diamine hydrochloride
CAS No.1640282-30-9

Synthetic Route by SureRoute

1. ACKPCA216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKPCA216 route product structure diagram
    ACKPCA2161640282-30-9
Inquiry

2. ACKPCA216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMOBY294 route compound structure diagram
    ACMOBY294151169-74-3 In Stock
  4. Then
  5. ACKPCA216 route product structure diagram
    ACKPCA2161640282-30-9
Inquiry

Comments (0)